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Abstract 
A novel substrate, 6-(4-nitrophenyl)dihydropyrimidine-2,4(1H,3H)-dione (pNO2PheDU), was chemically synthesized 
and analytically verified for the potential biocatalytic synthesis of enantiopure β-amino acids. The hydantoinase (EC 
3.5.2.2) from Arthrobacter crystallopoietes DSM20117 was chosen to prove the enzymatic hydrolysis of this substrate, 
since previous investigations showed activities of this enzyme toward 6-monosubstituted dihydrouracils. Whole 
cell biotransformations with recombinant Escherichia coli expressing the hydantoinase showed degradation of 
pNO2PheDU. Additionally, the corresponding N-carbamoyl-β-amino acid (NCarbpNO2βPhe) was chemically synthe-
sized, an HPLC-method with chiral stationary phases for detection of this product was established and thus (S)-enan-
tioselectivity toward pNO2PheDU has been shown. Consequently this novel substrate is a potential precursor for the 
enantiopure β-amino acid para-nitro-β-phenylalanine (pNO2βPhe).
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Introduction
The use of enantiopure β-amino acids is of increasing 
importance, since they are constituents of several bio-
logically active secondary metabolites such as taxol, jas-
pamide, theopalauamide and dolastatins (Weiner et  al. 
2010). As building blocks for β-peptides, which are able 
to form very stable and predictable secondary structures, 
they are also promising in applications as peptidomimet-
ics (Cheng et  al. 2001; Frackenpohl et  al. 2001; Seebach 
and Gardiner 2008). Furthermore, cyclized β-amino acids 
like β-lactams show encouraging pharmacological prop-
erties (Magriotis 2001), but also some β-amino acids in 
their free form (Juaristi 2005).
Chemical methods for the synthesis of β-amino acids 
attracted attention over the last decade, essentially based 
on classical resolution, stoichiometric use of chiral aux-
iliaries and homologation of α-amino acids (Liu and 
Sibi 2002; Juaristi 2005). However, when applying in an 
industrial scale, these strategies show limitations as res-
olutions of racemic mixtures are time consuming and 
cause high costs (Liu and Sibi 2002; Weiner et al. 2010). 
Alternatively, promising biocatalytical routes for the syn-
thesis of enantiopure β-amino acids, as the application 
of transaminases (Rudat et  al. 2012), monooxygenases 
(Rehdorf et  al. 2010) or aminomutases (Wu et  al. 2009) 
have been investigated. Most frequently, amino and 
ester functionalities in substrates are utilized for kinetic 
resolutions with hydrolytic enzymes. To date, the best 
exploited enzymes for the synthesis of β-amino acids are 
lipases, for example cleaving N-acetylated β-amino acids 
or racemic β-amino acid esters (Liljeblad and Kanerva 
2006; Tasnádi et al. 2008).
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Since kinetic resolutions merely enable a maximum 
yield of 50 %, lately the application of a modified hydan-
toinase process was proposed (Fig. 1b) (Engel et al. 2014). 
The latter is based on the classical hydantoinase process 
(Fig.  1a), which is well established in industry for the 
production of enantiopure α-amino acids 3 as α-(R)-
phenylglycine and α-(R)-p-hydroxyphenylglycine as side 
chains of the semisynthetic antibiotics ampicillin and 
amoxicillin (May et al. 2000; Bommarius et al. 2001). To 
date, whole cell biocatalysis is widely used due to low pro-
duction costs and simple separation of catalyst and prod-
uct (Slomka et  al. 2014). Together with the application 
of hydantoin racemases or spontaneous racemization of 
unreacted substrates (hydantoins, 1) under slightly alka-
line conditions (Ware 1950; Kato et al. 1987; Las Heras-
Vazquez et al. 2009), the enantioselectivity of the involved 
hydantoinase as well as carbamoylase cleaving the 
N-carbamoyl-α-amino acid 2 leads to a dynamic kinetic 
resolution and therefore a maximum yield of 100 %.
Compared to the hydrolysis of hydantoins toward 
α-amino acids, the hydrolysis of dihydropyrimidines 
4 to their N-carbamoyl derivatives 5 as a route to 
β-amino acids 6 has not been extensively studied yet. 
In 1998, May et  al. showed the hydrolysis of dihydro-
uracil by a hydantoinase of Arthrobacter aurescens and 
later this hydantoinase was successfully employed to 
hydrolyse 6-phenyldihydrouracil (May et  al. 1998; Servi 
et  al. 2005). Another group investigated the activity of 
the former commercially available hydantoinase from 
Vigna vulgaris toward differently substituted dihydro-
uracils (O’Neill et al. 2011). Even the second step of the 
modified hydantoinase process was realized by Martínez-
Goméz et  al.: The synthesis of α-methyl-β-alanine from 
5-methyl-5,6-dihydrouracil was accomplished using 
the dihydropyrimidinase from Sinorhizobium meliloti 
CECT4114 and the β-ureidopropionase from Agrobacte-
rium tumefaciens C58 (Martínez-Gómez et al. 2012).
In contrast to the classical hydantoinase process, one of 
the main challenging parameters of the process develop-
ment using 6-monosubstituted 5,6-dihydropyrimidines 
as substrates is to achieve a yield of 100  % of enantio-
pure product, since their chemical racemization is not 
yet known to occur and no suitable racemase is known 
(Martínez-Gómez et  al. 2012). Given that the viability 
of this route to β-amino acids was proven in some prior 
investigations (Engel et  al. 2012a, b; O’Neill et  al. 2011), 
in this work we chemically synthesized a novel substrate, 
6-(4-nitrophenyl)dihydropyrimidine-2,4(1H,3H)-dione 
(pNO2PheDU (R/S)-4a) and proved the hydrolysis of this 
compound by the hydantoinase from the gram positive 
soil bacterium A. crystallopoietes DSM20117. The enzyme 
was found to be enantioselective for this reaction, making 
pNO2PheDU (R/S)-4a) a promising precursor, since the 
resulting β-amino acid may offer specific properties itself 
as for example known for the β-amino α-hydroxy acid 
which is part of the antitumor agent paclitaxel (Taxol™) 
or regarding downstream chemistry (Fleming et al. 1993).
Materials and methods
Chemicals were of reagent grade and obtained 
from commercial sources if not stated otherwise. 
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Fig. 1 a Hydantoinase process for the synthesis of (R)-α-amino acids starting from racemic 5-monosubstituted hydantoins. b Proposed modified 
hydantoinase process for the synthesis of enantiopure β-amino acids starting from racemic 6-monosubstituted dihydrouracils
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((R)-para-nitro-β-phenylalanine) was purchased from 
Pep-Tech Corporation (Burlington, USA).
Media
The medium for cultivation and induction was lysogeny 
broth (LB) medium containing 10  g/L tryptone, 5  g/L 
yeast extract and 10 g/L NaCl. The pH was adjusted to 7 
with NaOH.
Bacterial strain, plasmid and expression
Escherichia coli JM109 harboring the plasmid pJAVI2 
(Werner et al. 2004) was cultured overnight in 20 mL LB 
medium containing ampicillin (100 µg/mL) in a shaking 
incubator at 37 °C and 120 rpm. The resulting preculture 
was added to 200 mL LB-medium in a 1 L shaking flask 
to an OD600 of 0.1 and incubated at 37 °C and 120 rpm. 
Induction was carried out at an OD600 of 0.4–0.6 by 
adding rhamnose (2 g/L final concentration) and subse-
quently the cultivation was carried out at 30 °C and 120 
rpm for an additional 6 h. After induction time, the cells 
were harvested by centrifugation (4700×g, 15 min, 4 °C), 
treated with liquid nitrogen and stored at −20 °C.
Assay of enzyme activity
For whole cell biotransformation reactions, the harvested 
E. coli cells were thawed on ice, washed twice with Tris–
HCl buffer (50 mM, pH 8) and resuspended in the same 
buffer (ratio of 10 mL buffer for 100 mL of harvested E. 
coli culture). Due to the poor water solubility, the sub-
strate solution was prepared by dissolving pNO2PheDU 
(40 mM) in DMSO and afterwards diluting to a concen-
tration of 4  mM with Tris–HCl buffer (50  mM, pH 8). 
The product solution of NCarbpNO2βPhe for analytical 
purposes was prepared in the same way. For starting the 
biotransformation reaction, 750 µL of the cell suspension 
was added to 750 µL of the prewarmed substrate solution 
to obtain a starting concentration of 2 mM pNO2PheDU 
(resulting in 25  mg cells per 1.5  mL reaction mixture). 
The assay was carried out in a thermomixer (Eppendorf) 
at 40  °C and 800  rpm for 24  h. Samples were taken at 
selected reaction times by withdrawing 200 µL from the 
reaction mixture, centrifugation (13,000 rpm, 5 min) and 
storage of the supernatant at −20 °C until analysis. For the 
determination of cell dry weight, 1.5 mL Eppendorf cups 
were dried overnight at 60  °C and subsequently weighed 
(triplicate). Thereafter, 1 mL of cell suspension was cen-
trifuged (13,000 rpm, 5 min) in these reaction vessels and 
again dried overnight at 60  °C. After discarding of the 
supernatant, the cell dry weight was determined.
Analytical procedures
1H  NMR spectra were recorded on a BRUKER Avance 
300 (300  MHz) or a BRUKER Avance 400 (400  MHz) 
device as solutions at room temperature. Chemical shifts 
are expressed in parts per million (ppm, δ), downfield 
from tetramethylsilane (TMS) and referenced to residual 
DMSO-d5 (2.50  ppm) as internal standard. All coupling 
constants are absolute values and J values are expressed 
in Hertz (Hz). The spectra were analyzed according to 
first order and the descriptions of signals include: s = sin-
glet, d = doublet, dd = doublet of doublets, t =  triplet, 
q = quartet, m = multiplet.
13C NMR spectra were recorded on a BRUKER Avance 
300 (75  MHz) or a BRUKER Avance 400 (100  MHz) 
device as solutions at room temperature. Chemical 
shifts are expressed in parts per million (ppm, δ), down-
field from tetramethylsilane (TMS) and referenced to 
DMSO-d6 (39.5  ppm) as internal standard. The signal 
structure was analyzed by DEPT and is described as fol-
lows: + =  primary or tertiary C-atom (positive signal), 
− = secondary C-atom (negative signal), and Cq = qua-
ternary C-atom (no signal).
Electron ionization mass spectrometry (EI–MS) and 
fast atom bombardment mass spectrometry (FAB-MS) 
was performed by using a Finnigan MAT 90 (70 eV). The 
molecular fragments are quoted as the relation between 
mass and charge (m/z), the intensities as a percentaged 
value relative to the intensity of the base signal (100 %). 
The abbreviation [M]+ refers to the molecule ion and 
[M + H]+ refers to the protonated molecule ion.
Infrared spectroscopy (IR) data were recorded on FT–
IR Bruker IFS 88 and are reported as follows: frequency 
of absorption (cm−1), intensity of absorption (vs =  very 
strong, s = strong, m = medium, w = weak, vw = very 
weak, br = broad).
Elemental analysis (EA) was carried out using an ELE-
MENTAR vario MICRO device. The values for carbon 
(C), hydrogen (H), and nitrogen (N) are expressed in 
weight percent.
HPLC analysis pNO2PheDU and NCarbpNO2βPhe 
were analyzed by HPLC on an Agilent 1200 system (Agi-
lent Technology, Santa Clara, USA) using a HyperClone 
ODS-C18 column (5 µm, 120 Å, 50 × 4.6 mm, Phenom-
enex). 5 µL of the sample were injected without any dilu-
tion. A gradient flow method with a 0.8 mL/min flow rate 
was used. The initial mobile phase was composed of 5 % 
(v/v) acetonitrile acidified with 0.5 % (v/v) trifluoroacetic 
acid and 95 % (v/v) bidest. water. From 0 to 25 min, the 
acetonitrile ratio was increased to 10 %, afterwards from 
25 to 26 min it was lowered to 5 % again. The detection 
wavelength was 257  nm and the column temperature 
22 °C.
Chiral analysis of NCarbpNO2βPhe was carried out uti-
lizing a Chiralpak QN-AX column (5 µm, 150 × 46 mm, 
Daicel, Chiral Technologies Europe, France). An isocratic 
flow method with 0.3  mL/min was used; the mobile 
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phase consisted of 98 % (v/v) methanol (0.2 % v/v ammo-
nium formate) and 2 % (v/v) acetic acid (0.2 M, adjusted 
to pH 6 with ammonia). The detection wavelength was 
257 nm, the column temperature was 30 °C and 5 µL of 
undiluted sample were injected.
Preparation of pNO2PheDU and the corresponding 
N‑carbamoyl derivative
6‑(4‑nitrophenyl)dihydropyrimidine‑2,4(1H,3H)‑dione 
(pNO2PheDU, 4a) (Svĕtlík and Veizerová 2011)
4-Nitrobenzaldehyde (7, 613 mg, 5.00 mmol, 1.00 equiv.), 
urea (8, 300 mg, 5.00 mmol, 1.00 equiv.) and meldrum’s 
acid (9, 721 mg, 5.00 mmol, 1.00 equiv.) were suspended 
in acetic acid (10 mL) and refluxed for 6 h. The product 
precipitated overnight. The solvent was removed under 
reduced pressure and the residue was recrystallized from 
EtOH. pNO2PheDU was obtained as a yellowish powder 
(489 mg, 2.08 mmol, 42 %).
1H NMR (400 MHz, DMSO-d6): δ = 2.66 (dd, 2J = 16.4, 
3J = 6.9 Hz, 1H, CH2), 2.91 (dd, 2J = 16.4, 3J = 5.9 Hz, 1H, 
CH2), 4.82–4.91 (m, 1H, CH), 7.62 (d, 3J =  8.8  Hz, 2H, 
2  ×  CHAr), 8.12 (s, 1H, NH), 8.25 (d, 3J  =  8.8  Hz, 2H, 
2 × CHAr), 10.25 (s, 1H, NH) ppm. 13C NMR (100 MHz, 
DMSO-d6): δ =  37.7 (−, CH2), 49.7 (+, CH), 123.8 (+, 
CHAr), 127.5 (+, 2 × CHAr), 147.0 (Cq, CNO2), 148.7 (Cq, 
2 × CAr), 153.7 (Cq, N(CO)N), 169.3 (Cq, N(CO)C) ppm. 
IR (ATR): ν˜ = 3233 (vw), 3075 (w), 2846 (vw), 1702 (m), 
1595 (vw), 1517 (w), 1487 (w), 1408 (w), 1342 (w), 1329 
(w), 1283 (w), 1235 (w), 1212 (w), 1159 (w), 1108 (w), 
1010 (vw), 991 (vw), 941 (vw), 849 (w), 764 (w), 731 (w), 
691 (w), 644 (vw), 615 (w), 581 (w), 531 (w), 511 (w), 462 
(vw), 441 (vw), 415 (w) cm−1. MS (EI, 70  eV), m/z (%): 
236 (7) [M + H]+, 235 (48) [M]+, 218 (13) [M − OH]+, 
177 (32), 164 (13), 151 (42), 149 (22), 119 (13), 113 (21), 
107 (100) [C6H6NO]+, 103 (17) [C4H5N2O2]+, 91 (11) 
[C7H7]+, 77 (43), 70 (41), 60 (22). HRMS (EI, C10H9O4N3): 
calc. 235.0588; found 235.0589. EA (C10H9O4N3) calc. C 
51.07 %, H 3.86 %, N 17.87 %; found C 50.87 %, H 3.72 %, 
N 17.62 %.
3‑(4‑Nitrophenyl)‑3‑ureidopropanoic acid (NCarbpNO2βPhe, 
5a)(Posner 1912)
4-Nitrophenylalanine (10, 488  mg, 2.38  mmol, 
1.00  equiv.) was added to a solution of potassium 
cyanate (565 mg, 7.14 mmol, 3.00 equiv.) in H2O (8 mL). 
The mixture was heated to reflux for 1  h. After cooling 
to room temperature, the solution was acidified with 
diluted aqueous HCl solution. The β-carbamoyl amino 
acid NCarbpNO2βPhe precipitated as a yellowish solid 
(418 mg, 1.65 mmol, 71 %).
1H  NMR (400  MHz, DMSO-d6): δ  =  2.71 (d, 
3J  =  6.9  Hz, 2H, CH2), 5.08 (q, 3J  =  7.2  Hz, 1H, CH), 
5.64 (s, 2H, NH2), 6.74 (d, 3J  =  8.4  Hz, 1H, NH), 7.58 
(d, 3J  =  8.6  Hz, 2H, 2  ×  CHAr), 8.19 (d, 3J  =  8.6  Hz, 
2H, 2  ×  CHAr) ppm. 13C NMR (100  MHz, DMSO-d6): 
δ = 40.9 (−, CH2), 49.9 (+, CH), 123.4 (+, CHAr), 127.7 
(+, 2 × CHAr), 146.3 (Cq, CAr), 151.8 (Cq, CAr), 157.8 (Cq, 
CO), 171.8 (Cq, CO2H) ppm. IR (ATR): v˜  =  3390 (w), 
1697 (m), 1631 (w), 1604 (w), 1506 (m), 1386 (w), 1345 
(m), 1313 (m), 1210 (m), 1176 (w), 1105 (w), 1035 (w), 
968 (w), 938 (w), 851 (m), 771 (vw), 751 (w), 700 (w), 649 
(w), 625 (w), 555 (m), 472 (m), 448 (m) cm−1. MS (FAB, 
3-NBA), m/z (%): 254 (23) [M + H]+, 233 (12), 192 (100). 
HRMS (FAB, (M+  +  H), C10H12O5N3): calc. 254.0771; 
found 254.0772.
Results
Preparation of pNO2PheDU and the corresponding 
N‑carbamoyl derivative
Several examinations already revealed the wide substrate 
scope of the hydantoinase of A. crystallopoietes DSM20117 
concerning hydantoins (Siemann et al. 1999). Furthermore 
the hydrolysis of dihydrouracils was discovered, making 
this enzyme a potential tool toward enantiopure β-amino 
acids applying a modified hydantoinase process (Engel 
et al. 2012b). Synthesis of a novel non-natural dihydroura-
cil pNO2PheDU ((R/S)-4a) (Svĕtlík and Veizerová 2011) 
for hydrolysis by the hydantoinase of A. crystallopoietes 
as well as the corresponding product ((R/S)-5a) (Posner 
1912) for analytical issues is shown in Fig. 2.
The synthesis of pNO2PheDU ((R/S)-4a, 489  mg, 
2.08  mmol, 42  %) and the corresponding N-carba-
moyl derivative NCarbpNO2βPhe ((R/S)-5a, 418  mg, 
1.65  mmol, 71  %) was carried out and verified with the 
methods described above.
Biocatalytic conversion of pNO2PheDU
After synthesis and analysis of the above mentioned com-
pounds, whole cell biotransformation reactions with E. 
coli hosting the recombinantly expressed hydantoinase 
employing pNO2PheDU ((R/S)-4a) as substrate were 
performed. The reaction was carried out in Tris–HCl 
(50  mM, pH 8) at 40  °C and 800  rpm for 24  h. Table  1 
shows the reaction course of pNO2PheDU concentration 
((R/S)-4a) as well as conversion yields during the entire 
reaction time.
The pNO2PheDU concentration (detected by HPLC) 
decreased from 1.94 to 1.63  mM within 1  h and finally 
to 0.54  mM after 24  h. Since control experiments per-
formed without cells did not show a decrease of substrate 
concentration below the initial concentration of 2  mM, 
the mentioned results prove chemical stability as well as 
the enzymatic hydrolysis of pNO2PheDU by the investi-
gated hydantoinase with a specific activity of 0.326 mU/
mgcdw. The observed conversion yield for the hydrolysis 
of the novel substrate was 72 % after 24 h.
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After successful hydrolysis of pNO2PheDU, we inves-
tigated the enantioselectivity of the applied hydan-
toinase regarding applications in pharmaceutical 
industries.
Enantioselectivity of the hydantoinase from A. 
crystallopoietes for pNO2PheDU
As shown above, by performing whole cell biotransfor-
mation reactions, the hydrolysis of pNO2PheDU (4a) via 
A. crystallopoietes hydantoinase was proven. To inves-
tigate the enantiopreference of this enzyme toward the 
novel substrate, HPLC analytics with chiral stationary 
phases have been established. The enantiomers of the 
product were successfully separated with retention times 
of 13.2 and 14.4 min for the (S)- and (R)-enantiomer (see 
Fig. 3a).
By comparing the separation of the NCarbpNO2βPhe 
((R/S)-5a) standard with the product formed after 24  h 
of biotransformation, a preference of the hydantoin-
ase for the (S)-enantiomer was observed, consistent to 
the results reported before. More precisely, 0.77 mM of 
(S)-NCarbpNO2βPhe ((S)-5a) emerged after 24  h (see 
Fig.  3b). However, only 0.08  mM of the (R)-enantiomer 
were detected after a reaction time of 24 h. Consequently, 
within the first 5  h of whole cell biotransformation an 
enantioselectivity of  >99  % ee was achieved, while after 
24  h the enantiomeric excess was 80.4  % ee. Control 
experiments without cells do not reveal any product for-
mation (data not shown), confirming the conversion of 
the novel substrate to the corresponding N-carbamoyl-
β-amino acid by the hydantoinase of A. crystallopoietes 
with preference to the (S)-enantiomer.
Discussion
Since the use of enantiopure β-amino acids is of increas-
ing interest for applications in pharmaceutical industries, 
we focused on a modified hydantoinase process, which is 
based on the well established classical hydantoinase pro-
cess for the production of enantiopure α-amino acids. 
The viability of the first step in this proposed modified 
hydantoinase process, the hydrolysis of dihydrouracil as 
well as the hydrolysis of differently substituted dihydro-
uracils was shown in previous works (May et  al. 1998; 
Servi et al. 2005; O’Neill et al. 2011).
In this study, the chemical synthesis of the novel function-
alized dihydrouracil pNO2PheDU (4a) was accomplished. 
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Fig. 2 Synthesis of pNO2PheDU (a, (R/S)-4a) and the corresponding N-carbamoyl-β-amino acid (b, (R/S)-5a)
Table 1 Conversion of  pNO2PheDU ((R/S)-4a) during  24  h 
whole cell biocatalysis with  recombinant E. coli JM109 
expressing the hydantoinase of A. crystallopoietes
a Initial substrate concentration: 2 mM. Reactions and measurements were 
carried out in triplicates. Detection by HPLC Agilent 1200 system (HyperClone 
ODS-C18 column; 257 nm, 22 °C, 0.8 mL/min; initial mobile phase: 5 % (v/v) 
acetonitrile acidified with 0.5 % (v/v) trifluoroacetic acid and 95 % (v/v) bidest. 
water, 0-25 min: acetonitrile ratio increased to 10 % (v/v), 25–26 min acetonitrile 
ratio lowered to 5 % (v/v)
Time (h) pNO2PheDU
a (mM) Conversion (%)
0 1.94 ± 0.03 –
1 1.63 ± 0.05 16
2 1.29 ± 0.04 34
3 1.24 ± 0.02 36
4 1.18 ± 0.04 39
5 1.16 ± 0.11 40
24 0.54 ± 0.05 72
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Additionally, the corresponding N-carbamoylamino acid 
was chemically prepared for analytical issues. Thereupon, 
the hydrolysis of this substrate by the hydantoinase from 
A. crystallopoietes DSM20117 was investigated in terms 
of the synthesis of enantiopure β-amino acids. Performing 
whole cell biotransformation experiments, the enzymatic 
hydrolysis of pNO2PheDU (4a) could be shown with the 
highest level of specific activity after 2  h with 0.326  mU/
mgcdw and a total conversion yield of 72.27  % after 24  h. 
To exclude a possible chemical degradation or thermal 
instability of the substrate, control experiments without 
cells have been conducted. The latter showed no decrease 
of substrate concentration and therefore the enzymatic 
hydrolysis of pNO2PheDU (4a) by the hydantoinase from 
A. crystallopoietes DSM20117 was verified. A limiting fac-
tor in this approach is the low solubility of the substrate. 
By addition of 5 % DMSO, we achieved an initial substrate 
concentration of 2 mM. It remains to be examined whether 
higher initial substrate concentrations with higher contents 
of DMSO would lead to increased enzyme activities or 
enzyme inactivation (Arcuri et al. 2003).
The successful separation of both enantiomers of 
the product NCarbpNO2βPhe allowed investigation 
of the enantiopreference of this hydantoinase toward 
pNO2PheDU (4a). During the first 5 h of biotransforma-
tion an enantiomeric excess of >99 % ee for the (S)-enanti-
omer was demonstrated, decreasing to 80.4 % ee after 24 h. 
As mentioned earlier, due to the low solubility of the sub-
strate pNO2PheDU (4a), a maximum final concentration 
of 2 mM was achieved. Thus, since no substrate saturation 
was accomplished, we suggest that after hydrolysis of the 
preferred (S)-pNO2PheDU (4a), the hydantoinase starts 
converting the (R)-enantiomer of the racemic substrate. 
Another alternative is a spontaneous racemization of the 
product. This has also been monitored by HPLC analyt-
ics with chiral stationary phases and no racemization was 
observed for (S)-NCarbpNO2βPhe ((S)-5a) in Tris–HCl 
(50 mM, pH 8) at 40 °C during 48 h. Consequently, in con-
trast to the hydantoins tested to date, we could show that 
the novel substrate pNO2PheDU (4a) has been hydrolyzed 
with preference of the (S)-enantiomer, which is consist-
ent with previous studies concerning other dihydrouracils 
(O’Neill et al. 2011; Engel et al. 2012b).
However, there is still a limiting factor for synthesis of 
the enantiopure β-amino acid with 100 % yield: the race-
mization of the applied substrate. As already mentioned, 
the racemization of dihydrouracils 4 is challenging com-
pared to hydantoins given that no keto-enol-tautomerism 
occurs. There are not many investigations concerning 
this topic, but Argyrou et al. examined the interchange of 
protons in the carbon 5 (C5) and revealed spontaneous 
racemization of 5-monosubstituted 5,6-dihydrouracils 
due to the acidic proton at a carbon next to a carbonyl 
group. In contrast, for dihydroorotate (6-carboxy-
dihydrouracil) no racemization was observed (Argyrou 
and Washabaugh 1999). This was approved for further 
6-monosubstituted dihydrouracil derivatives by Mar-
tínez-Gómez et al. (Martínez-Gómez et al. 2012). Due to 
the chosen synthesis strategy for the novel 6-monosubsti-
tuted dihydrouracil, until now we could not achieve the 
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Fig. 3 Studies on the enantioselectivity of the hydantoinase from A. crystallopoietes toward pNO2PheDU ((R/S)-4a). a Chiral separations in order to 
determine the enantioselectivity of the hydantoinase pNO2PheDU ((R/S)-4a) as substrate in whole cell biocatalysis with recombinant E. coli JM109. 
Solid line separation of 2 mM NCarbpNO2βPhe standard ((R/S)-5a), dashed line separation of NCarbpNO2βPhe ((R/S)-5a) after 24 h biotransformation. 
b Concentrations of the (S)- and (R)-enantiomer (empty circles and filled circles) and enantiomeric excess (filled triangles) during the reaction progress. 
Reactions and measurements were carried out in triplets and error bars show the standard deviations of the means. Detection by HPLC Agilent 
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synthesis of enantiopure pNO2PheDU (4a) in terms of 
analyzing the racemization of this dihydrouracil.
Nevertheless, the findings of this work represent a 
promising basis to employ the novel substrate for the 
synthesis of optically pure β-amino acids by further con-
version of the resulting N-carbamoyl-β-amino acid. In 
previous approaches, the hydrolysis of N-carbamoyl-β-
amino acids was performed chemically (O’Neill et  al. 
2011). Therefore it is worthwhile to detect an appropri-
ate carbamoylase (EC 3.5.1.77; EC 3.5.1.87) realizing this 
reaction to gain β-amino acids. β-Ureidopropionases 
(EC 3.5.1.6) may also be prospect enzymes since they 
catalyze the last step of the reductive pyrimidine 
degradation pathway, hydrolyzing N-carbamoyl-β-
alanine and β-ureidoisobutyric acid to β-alanine and 
β-aminoisobutyric acid (Martínez-Gómez et al. 2012).
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